zidovudine has been researched along with Hematologic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Einarsson, R; Eriksson, S; Grassi, J; Lindh, M; Ohrvik, A | 1 |
| Augustyniak, C; Evens, AM; Gordon, LI; Gupta, R; Mehta, J; Ziegler, SL | 1 |
| Anderson, LM; Diwan, BA; Haines, DC; Logsdon, D; Olivero, OA; Poirier, MC; Rice, JM; Riggs, CW; Yuspa, SH | 1 |
3 other study(ies) available for zidovudine and Hematologic Neoplasms
| Article | Year |
|---|---|
Sensitive nonradiometric method for determining thymidine kinase 1 activity.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dideoxynucleotides; Female; HeLa Cells; Hematologic Neoplasms; Humans; Immunoenzyme Techniques; Prohibitins; Regression Analysis; Reproducibility of Results; Thymidine Kinase; Thymine Nucleotides; Zidovudine | 2004 |
Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Central Nervous System Neoplasms; Diphtheria Toxin; Drug Resistance, Neoplasm; Hematologic Neoplasms; Humans; Interferons; Interleukin-2; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Recombinant Fusion Proteins; Recurrence; Remission Induction; Transplantation, Homologous; Zidovudine | 2007 |
Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.
Topics: Animals; Animals, Newborn; Anti-HIV Agents; Barbital; Body Weight; Carcinogens; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Maternal-Fetal Exchange; Mice; Neoplasms, Experimental; Pregnancy; Survival Rate; Time Factors; Urogenital Neoplasms; Zidovudine | 1999 |